Related Experiment Video
Updated: Jun 19, 2026
10:00
High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
Published on: March 24, 2015
Endogenous type I interferon inducers in autoimmune diseases.
Doreen Finke1, Maija-Leena Eloranta, Lars Rönnblom
1Section of Rheumatology, Department of Medical Sciences, Uppsala University, SE-75185, Uppsala, Sweden.
Autoimmunity
|October 9, 2009
Summary
Type I interferon (IFN) production in autoimmune diseases is triggered by immune complexes containing nucleic acids. Specific nucleic acid configurations and other components like HMGB1 are crucial for initiating this innate immune response.
Area of Science:
- Immunology
- Autoimmune Diseases
- Innate Immunity
Background:
- Type I interferon (IFN) is implicated in autoimmune diseases like systemic lupus erythematosus (SLE).
- Immune complexes (IC) containing nucleic acids (NA) may function as endogenous IFN inducers in these conditions.
- Plasmacytoid dendritic cells (PDC) play a central role in initiating IFN production.
Purpose of the Study:
- To elucidate the mechanisms of type I IFN induction by IC in autoimmune diseases.
- To identify key molecular components and nucleic acid configurations involved in IFN production.
- To explore the genetic basis of IFN-related gene variants in autoimmune disease susceptibility.
Main Methods:
- Investigated the role of IC-containing DNA and RNA in triggering type I IFN.
- Examined the intracellular localization of IC within PDC and their interaction with Toll-like receptors (TLR).
- Analyzed the structural characteristics of NA (e.g., CpG-rich DNA, GU-rich RNA) and other IC components (e.g., HMGB1).
Main Results:
- Specific NA configurations, such as non-methylated CpG-rich DNA and GU-rich RNA, are critical for IFN induction.
- The uptake of IC by PDC and subsequent TLR activation initiate a transcription factor cascade leading to type I IFN production.
- HMGB1 and other IC components may be essential for this process.
Conclusions:
- Understanding the molecular triggers of type I IFN production is vital for autoimmune disease pathogenesis.
- Genetic factors influencing IFN production and response pathways contribute to autoimmune disease susceptibility.
- This knowledge provides a foundation for developing novel therapeutic strategies targeting IFN pathways in autoimmune diseases.
Related Concept Videos
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:29Autoimmune Disorders
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Concept and Mechanism of Autoimmune Diseases
The immune system...
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...